Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-055599

Chief Financial Officer sold 29,166 shares at $54.04 ($1,576,131)

  • Chief Financial Officer acquired 29,166 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2020-10-20 Option exercise +29,166 $6.15 $179,371 456,834 D
Myszkowski Kenneth Allen Chief Financial Officer 2020-10-20 Sale −29,166 $54.04 $1,576,131 427,668 D
Derivatives
Myszkowski Kenneth Allen Chief Financial Officer 2020-10-20 Option exercise · Stock Option (right to buy) −29,166 43,505 D
Open-market sales · 29,166 sh · avg $54.04 · $1,576,131
Loading xslF345X03/doc4.xml…